Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
This Phase 2 trial evaluated the combination of docetaxel and gemcitabine in patients with stage IIIB or stage IV non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating vinorelbine in older patients with stage IIIB or stage IV non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Positron Emission Tomography for Detecting Non-small Cell Lung Cancer [NA]
The document notes the completion of a clinical trial evaluating positron emission tomography for detecting non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma
Clinical trial evaluating whether adding Chinese herbal medicine to EGFR-TKI improves outcomes in advanced non-small cell lung cancer, compa…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer [Phase 3]
This Phase 3 clinical trial evaluating chemotherapy with or without radiation therapy for stage IIIA non-small cell lung cancer has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial evaluating erlotinib plus dovitinib (TKI258) in advanced non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation
This update reports responses to chemotherapy in patients with non-small cell lung cancer who harbor a known somatic activating HER2 mutatio…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 trial studied pemetrexed disodium in combination with bevacizumab for stage III or IV non-small cell lung cancer, and the study…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
A completed clinical trial evaluating whether proteomic profiling can diagnose non-small cell lung cancer in patients undergoing lung resect…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
This clinical trial update presents results from a completed study analyzing tissue and blood biomarkers in patients with early-stage non-sm…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating irinotecan in combination with docetaxel for recurrent or metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial update evaluating the combination of chemotherapy with fluoxetine for advanced or recurrent non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC [Phase 3]
A Phase 3 study comparing ganetespib plus docetaxel versus docetaxel alone in advanced non-small cell lung cancer was terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
This clinical trial update reports on a completed study evaluating breath analysis as a non-invasive method to assess radiation exposure in …
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors [Phase 2]
Phase 2 results evaluating combined modality treatment for resectable non-small cell lung cancer in the superior sulcus (Pancoast) region.
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and gemcitabine with celecoxib and/or zileuton in advanced non-small cell lung cancer has completed. No…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer [NA]
This clinical trial update reports on evaluating sentinel lymph node mapping to detect cancer spread to lymph nodes in patients with non-sma…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel with or without carboplatin in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 trial studied docetaxel and cisplatin with or without dimesna in stage IIIB/IV non-small cell lung cancer and has completed; ad…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer
A completed clinical trial evaluated EGFR and KRAS mutation status in patients with stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
This clinical trial update describes completion of a study focused on detecting early metastases in patients with stage I non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating chidamide in combination with an EGFR tyrosine kinase inhibitor for advanced EGFR-TKI-resistant non-small …
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin [Phase 3]
Phase 3 trial evaluates first-line treatment with necitumumab plus gemcitabine and cisplatin in stage IV squamous non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer [Phase 2]
A Phase 2 study evaluating first-line treatment of squamous non-small cell lung cancer with gemcitabine-cisplatin chemotherapy plus necitumu…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients [Phase 3]
A Phase 3 trial evaluated the efficacy of integrated traditional Chinese medicine with chemotherapy in postoperative non-small cell lung can…